CAS 1038620-68-6

Formula: C29H33FN8O

InChI: InChI=1S/C29H33FN8O/c30-20-5-4-6-24(17-20)38-18-32-25-26(35-29(36-27(25)38)34-23-13-9-21(31)10-14-23)33-22-11-7-19(8-12-22)28(39)37-15-2-1-3-16-37/h4-8,11-12,17-18,21,23H,1-3,9-10,13-16,31H2,(H2,33,34,35,36)

InChI key: KRCOMOOXOZSNAJ-UHFFFAOYSA-N

SMILES: C1CCN(CC1)C(=O)C2=CC=C(C=C2)NC3=C4C(=NC(=N3)NC5CCC(CC5)N)N(C=N4)C6=CC(=CC=C6)F

Purfalcamine

CAS: 1038620-68-6

Purfalcamine

Formula: C₂₉H₃₃FN₈O

Purity: 99.71%

Molecular weight: 528.62

Ref: 54-PC1029040

Purfalcamine

CAS: 1038620-68-6

Formula: C₂₉H₃₃FN₈O

Purity: 99.71%

Color and Shape: Solid

Molecular weight: 528.6237

Ref: IN-DA01V7FP

Purfalcamine

CAS: 1038620-68-6

Purfalcamine is a synthetic pharmaceutical compound that belongs to a class of molecules known as small-molecule inhibitors. It is sourced through advanced chemical synthesis, enabling precise structural modifications to optimize its biological activity. The mode of action of Purfalcamine involves selective inhibition of a specific target protein involved in key cellular signaling pathways. This targeted interaction disrupts abnormal cellular processes, making it a promising therapeutic candidate for certain diseases.

Formula: C₂₉H₃₃FN₈O

Purity: Min. 95%

Molecular weight: 528.6 g/mol

Ref: 3D-NRB62068

Purfalcamine

CAS: 1038620-68-6

Purfalcamine, a selective PfCDPK1 inhibitor effective against malaria, has IC50 of 17 nM and EC50 of 230 nM; halts parasites at schizont stage.

Formula: C₂₉H₃₃FN₈O

Color and Shape: Solid

Molecular weight: 528.62

Ref: TM-T38269